Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shijiazhuang Yiling Pharmaceutical Co., Ltd., a national key high-tech enterprise, was established on June 16, 1992. The company aims to "inherit innovation and benefit humanity", with "technology for a healthy tomorrow" as its development goal, healthy human beings as its own responsibility, and society as its aspiration. It always adheres to the innovative development strategy of market leading and technology driven, Drive the industrialization of traditional Chinese medicine through academic innovation in traditional Chinese medicine, and use modern high-tech to develop traditional Chinese medicine, Western medicine, and biopharmaceuticals. Establish a unique operational model that integrates theory, clinical practice, scientific research, industry, and teaching. We have undertaken more than 40 national and provincial level projects, including two national 973, national 863, national natural science foundation, and national key research and development plans. We have developed more than 10 patented new drugs, including Tongxinluo capsules for treating coronary heart disease and cerebral infarction, Shensong Yangxin capsules for treating both fast and slow arrhythmia, Qili Qiangxin capsules for treating chronic heart failure, and Lianhua Qingwen capsules for treating colds and anti influenza. As of December 31, 2020, we have obtained 660 patents, Has won more than 30 national and provincial level science and technology awards, including the First Prize of National Science and Technology Progress Award, the Second Prize of National Science and Technology Progress Award, and the Second Prize of National Technology Invention Award. The company has established production bases in Shijiazhuang, Hengshui, Hebei, Daxing, Miyun, and other places in Beijing, creating a perfect production layout, ensuring product supply, introducing advanced domestic and foreign equipment and pharmaceutical processes, creating a comprehensive quality control system that meets international standards, ensuring the safety of consumer medication, establishing a strong marketing network and academic marketing team, and forming three major business sectors: scientific and technological traditional Chinese medicine, chemical and biological medicine, and health industry, The influence in the pharmaceutical industry continues to grow, and it is one of the top 10 Chinese herbal medicine companies, the top 20 listed pharmaceutical companies in China, and the top 500 listed companies in China (stock code 002603). |
| Headquarter | Shijiazhuang |
| Establish Date | 8/28/2001 |
| Listed Code | 002603.SZ |
| Listed Date | 7/28/2011 |
| Chairman | Wu Xiangjun. |
| CEO | Wu Xiangjun. |
| Website | www.yiling.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
